Lord Abbett Health Care Fund Class R6 (LHCVX)

Fund Assets	3.27M
Expense Ratio	0.68%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	0.11
Dividend Yield	0.61%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Nov 26, 2024

Previous Close	17.98
YTD Return	-8.59%
1-Year Return	-7.21%
5-Year Return	26.25%
52-Week Low	16.79
52-Week High	21.15
Beta (5Y)	n/a
Holdings	66
Inception Date	Jul 31, 2019

About LHCVX

The Fund's investment strategy focuses on Health/Biotech with 0.7% total expense ratio. Lord Abbett Securities Trust: Lord Abbett Health Care Fund; Class R6 Shares seeks long-term capital appreciation. Under normal market conditions, LHCVX will invest at least 80% of its assets in equity and equity-related securities of health care-related companies. LHCVX may invest in the securities of issuers of different countries throughout the world, including the United States.

• Category: Health
• Performance Rating: Above Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: LHCVX
• Share Class: Class R6
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCVX had a total return of -7.21% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.60%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCFX	Class F	0.78%
LHCIX	Class I	0.78%
LHCTX	Class R5	0.78%

Top 10 Holdings

40.46% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	8.74%
Boston Scientific Corporation	BSX	4.92%
Intuitive Surgical, Inc.	ISRG	4.78%
Gilead Sciences, Inc.	GILD	3.94%
Stryker Corporation	SYK	3.74%
argenx SE	ARGX	3.56%
Natera, Inc.	NTRA	3.06%
Tarsus Pharmaceuticals, Inc.	TARS	2.94%
Cencora, Inc.	COR	2.61%
UCB SA	UCB	2.14%

Dividend History

Ex-Dividend	Amount	Pay Date
Nov 26, 2024	$0.1097	Nov 26, 2024
Nov 22, 2022	$0.0471	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3345	Nov 24, 2020
Nov 21, 2019	$0.0104	Nov 21, 2019